MustGrow Biologics Corp. (TSXV:MGRO)

Market Cap	56.29M
Revenue (ttm)	398.02K
Net Income (ttm)	-4.89M
Shares Out	51.64M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,550
Average Volume	6,943
Open	1.070
Previous Close	1.110
Day's Range	1.050 - 1.090
52-Week Range	0.620 - 2.530
Beta	2.42
RSI	48.94
Earnings Date	Apr 24, 2025

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: MGRO

Financial Performance

In 2024, MustGrow Biologics's revenue was 398,018, a decrease of -91.55% compared to the previous year's 4.71 million. Losses were -4.89 million, 622.2% more than in 2023.